HRTX HERON THERAPEUTICS, INC. /DE/

$0.42 +7.55%

Healthcare · Pharmaceutical Preparations

HERON THERAPEUTICS, INC. /DE/ (HRTX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $79 million. Shares last traded at $0.42, 81.9% below their 52-week high. Over the past year the stock is down 78.6%. Net profit margin is -12.9%, below the peer median of -0.1%. Revenue grew 7.4% year over year.

Market Cap

$79M

Shares Out

189.3M

EPS (TTM)

$-0.14

P/E Ratio

—

P/S Ratio

0.51

P/B Ratio

8.64

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.30

52-Week Low

$0.39

Volume

249,849

Avg Vol (3m)

93,899.873

Performance

+3.32%

-50.76%

-48.94%

-69.99%

YTD

-66.89%

-78.61%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

27.41

SMA (50)

$0.85

SMA (200)

$1.11

Price vs SMA50

-51.18%

Price vs SMA200

-62.37%

ATR (14)

$0.05

Financials

Revenue

$155M

Net Income

$-20M

Gross Margin

73.3%

Operating Margin

-1.6%

Net Margin

-12.9%

Return on Equity

-218.9%

Return on Assets

-8.1%

Current Ratio

2.53

Debt / Equity

25.95

Revenue Growth (YoY)

+7.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.04	2026-05-11
FY 2025	$-0.12	2026-02-26
Q3 2025	$-0.11	2025-11-04
Q2 2025	$0.00	2025-08-08
Q1 2026	$0.01	2026-05-11
FY 2025	$-0.09	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

HRTX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

0.51 / 3.54 med

-86% discount

Net margin vs peers

-12.9% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.